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Wrnip1 (Werner helicase-interacting protein 1) has been
implicated in the bypass of stalled replication forks in bakers’
yeast. However, the function(s) of humanWrnip1 has remained
elusive so far. Here we report that Wrnip1 is distributed inside
heterogeneous structures detectable in nondamaged cells
throughout the cell cycle. In an attempt to characterize these
structures, we found that Wrnip1 resides in DNA replication
factories. Upon treatments that stall replication forks, such as
UVC light, the amount of chromatin-bound Wrnip1 and the
number of foci significantly increase, further implicating
Wrnip1 inDNAreplication. Interestingly, thenuclear patternof
Wrnip1 appears to extend to a broader landscape, as it can be
detected in promyelocytic leukemia nuclear bodies. The pres-
ence ofWrnip1 into these heterogeneous subnuclear structures
requires its ubiquitin-binding zinc finger (UBZ) domain, which
is able to interactwithdifferent ubiquitin (Ub) signals, including
mono-Ub and chains linked via lysine 48 and 63. Moreover, the
oligomerization of Wrnip1 mediated by its C terminus is also
important for proper subnuclear localization. Our study is the
first to reveal the composite and regulated topography of
Wrnip1 in the human nucleus, highlighting its potential role in
replication and other nuclear transactions.
Progression of DNA replication forks can be halted by DNA
lesions or secondary structures, tight DNA-protein complexes,
or the lack of deoxyribonucleotides (1). Several solutions have
been selected throughout evolution to allow for the bypass of
stalled replication forks and resume DNA synthesis. These
include translesion synthesis, fork regression, and homologous
recombination (1, 2). Failure in recovery of stalled replication
forks may result in single and double strand DNA breaks,
genomic instability, and if persistent, carcinogenesis (1).
Mgs1 (maintenance of genomic stability 1) was originally
identified in bakers’ yeast Saccharomyces cerevisiae as an evo-
lutionarily conserved AAA ATPase important for maintain-
ing genomic stability (3). Subsequently, themouseMgs1 ortho-
logue, Wrnip1 (Werner-interacting protein 1) was cloned as a
binder of the helicase (Wrn) mutated in the Werner syndrome
(4, 5). Telomere aberrations and defective telomere lagging-
strand replication have been proposed to be a key patho-mech-
anism of this very rare premature aging condition, which
remarkably recapitulates the main features of physiological
aging (6, 7). In S. cerevisiae,mgs1 was found to be synthetically
lethal with the rad6 and rad18 genes involved in DNA damage
tolerance, indicating thatMgs1/Wrnip1might deal with stalled
replication forks (8). A further study demonstrated that yeast
Mgs1 can physically interact with the DNA loading clamp
PCNA4 and suggested that Mgs1 may participate in a DNA
damage tolerance pathway alternative to the Rad6-Rad18 one
(9). The inferred role of Mgs1/Wrnip1 in replication has been
strengthened by the evidence that Mgs1 in vitro stimulates the
activity of Fen1, an endonuclease indispensable for the removal
of Okazaki fragments during lagging-strand replication (10).
Additionally, purified human Wrnip1 can interact with DNA
polymerase  and increase the initiation efficiency of DNA rep-
lication in vitro (11). Besides a possible function in DNA repli-
cation, humanWrnip1 has also been shown to selectively bind
ubiquitin (Ub) chains but not mono-Ub and has been proposed
to regulate the turnover of ubiquitylated proteins (12). How-
ever, the precise function(s) ofWrnip1 in mammalian cells still
remain unclear. It is conceivable that studies aimed at elucidat-
ing the function(s) of Wrnip1 in more detail may reveal unex-
pected insights in themechanisms ofDNAreplication and their
link to aging.
Here we show that in the nucleus of cultured cells human
Wrnip1 is concentrated in a variety of structures,most of which
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have a punctated, focal appearance and are visible throughout
the cell cycle. A number of these foci overlap with replication
factories, and the presence of Wrnip1 at DNA replication sites
is greatly increased upon conditions that stall replication forks,
such as UVC. Additionally, a proportion of Wrnip1 foci co-
localize with promyelocytic leukemia (PML) bodies, independ-
ently of the cell cycle phase. Interestingly, the presence of
Wrnip1 inside the aforementioned structures seems to specif-
ically require its Ub-binding zinc finger domain (UBZ) as well
as its ability to form oligomers. The presence ofWrnip1 at sites
other than replication foci also hints at possible functions of
this protein beyond DNA replication, which certainly deserve
future attention.
EXPERIMENTAL PROCEDURES
Molecular Cloning—The following constructs were gener-
ated using the indicated restriction enzymes: pcDNA3.1-
FLAG-Wrnip1 Mm and pGEX-Wrnip1 Hs (EcoRI and
XhoI); pEGFP-N1-Wrnip1 Hs (EcoRI and BamHI); pGEX-
UBZWrnip1 Hs (EcoRI and XhoI); pcDNA3.1-Myc-Rad18 Hs
and pcDNA3.1-FLAG-Myc-Rad18 (EcoRI). pGEX-Ub and
pGEX-Ub I44A have been described previously (13). Also
pETM-30-UBZRad18Hs has been described elsewhere (14). The
cDNA used as a template in the generation of Wrnip1 con-
structs was obtained from the genomic consortium RZPD. The
template for Rad18 constructs was HA-Rad18, which has been
described previously (13). pBABE.puro-Wrnip1-EGFP was
constructed by amplifying Wrnip1-EGFP from pEGFP-N1-
Wrnip1 with primers containing the cleavage sequence of
EcoRI. Substitution of Asp-37 to Ala inWrnip1 and of Asp-221
to Ala in Rad18 was performed by PCR site-directed mutagen-
esis. The pBABE.puro-Wrnip1-EGFP and the pcDNA3.1-
FLAG-Myc-Rad18 UBZ chimeras were obtained using the
megaprimermutagenesismethod (15) and the sequence ofMus
musculus polymerase , Homo sapiens polymerase , and H.
sapiensWrnip1.
Antibodies and Other Chemicals—Anti-FLAG antibodies
were from Sigma (M2 catalog number F3165 and M5 catalog
number F4042), anti-PML (catalog number sc-966), anti-hem-
agglutinin (catalog number sc-7392), and anti-Myc (catalog
number sc-40) antibodies from Santa Cruz Biotechnology,
anti-Wrnip1 from GeneTex (catalog number GTX24731), and
anti-EGFP from BD Biosciences (Living Colors catalog num-
ber 632460).
Recombinant Proteins—The indicated GST fusions were
obtained by inducing transformed Escherichia coli BL21 with
0.3 mM isopropyl 1-thio--D-galactopyranoside, when the cul-
ture reached A600 1, and growing them overnight at 15 °C.
Bacteria were then harvested in HEPES 20 mM, NaCl 150 mM,
ZnCl2 2M, and-mercaptoethanol 0.05%, supplementedwith
protease inhibitors just prior to use. The bacterial suspension
was sonicated, and the lysate was cleared and then flown
through a GSTrapTMHP column (GEHealthcare) mounted on
an Äktaprime Plus chromatographic system (GE Healthcare).
When indicated, GST was cleaved with thrombin (Amersham
Biosciences).
Cell Culture, Transfection, and Synchronization—HEK
293T, Amphotropic Phoenix HEK 293, and HeLa cells were
purchased from the American Tissue Culture Collection
(ATCC) and grown in DMEM high glucose medium (Invitro-
gen), supplemented with penicillin (100 units/ml) and strepto-
mycin (100 g/ml) and 10% fetal bovine serum. After infection,
HeLa cells were selected in the presence of 3 g/ml puromycin.
HEK 293T were transfected using Lipofectamine reagent
(Invitrogen) according to the manufacturer’s instructions.
HeLa and Phoenix Amphotropic 293 cells were transfected
using Effectene (Qiagen).
For lysis, cells were incubated with a “Triton” buffer contain-
ing HEPES 50mM, pH 7.5, NaCl 150mM, EDTA 1mM, EGTA 1
mM, Triton X-100 1%, glycerin 10%, NaF 25mM, supplemented
with protease inhibitors. The lysate was cleared, the superna-
tant collected (Triton X-100-soluble fraction), and the Triton-
insoluble pellet resuspended in a buffer containing HEPES 50
mM, pH 7.4, NaCl 50mM,MgCl2 2mM, Triton X-100 0.1%, SDS
0.05%, and 2.5 units per l of lysate of Benzonase nuclease
(Novagen). After 1 h of incubation at 4 °C, the suspension was
centrifuged and the supernatant (Triton X-100-insoluble frac-
tion) mixed with the Triton X-100-soluble fraction.
For synchronization, cells seeded on 10-cm Petri dishes con-
taining one 12-mm coverslip per dish were grown to a conflu-
ency of 20–30%. At this point, thymidine was added to a final
concentration 2 mM. After 18 h, cells were washed in PBS and
put in fresh medium without thymidine. A second 17-h block
was repeated 8 h after the first thymidine washout. At the time
of the second release, a coverslipwas taken formicroscopy from
one dish, whereas the remaining cells in the same dish were
trypsinized and fixed in 70% ethanol. This procedure was
repeated 5, 9, and 12 h after thymidine withdrawal. For cell
cycle analysis, fixed cells were washed three times in PBS and
resuspended in 2 ml of PBS containing 0.1% Triton X-100, 40
g/ml propidium iodide (Sigma), and 100 g/ml DNase-free
RNase (Qiagen). After 30min of incubation at 37 °C in the dark,
the cell cycle distribution was analyzed using a Epics XL cyt-
ofluorimeter (BeckmanCoulter) and the EXPOTM32ADCsoft-
ware (Beckman Coulter).
Virus Preparation and Infections—Retroviruses were pro-
duced by transfecting Amphotropic Phoenix HEK 293 cells
with pBABE.puro constructs. Transfections were performed in
100-mm diameter dishes using Effectene (Qiagen), according
to the manufacturer’s instructions. Virus-containing superna-
tants were collected 24 and 48 h after transfection, cleared
through a 0.2-mpore diameter filter and supplementedwith 8
g/ml Polybrene (Sigma). 24 h after transfection, 5–10  104
target cells per well in a 6-well plate were infectedwith 500l of
viral supernatant, and the medium was replaced after 8 h. The
same procedure was repeated 48 h after transfection. 72 h after
the first infection, selection of the infected cells was performed
by adding puromycin to the growth medium.
Immune Precipitations and GST Pulldowns—Immune pre-
cipitations and pulldownswere done lysing a confluent well of a
6-well format plate with 500 l of Triton buffer, and using 200
l of lysate plus 200 l of Triton buffer per reaction. After
adding the indicated antibodies or GST fusions, the mixture
was rotated for 4 h at 4 °C. In the case of immune precipitations,
20 l of agarose-protein A were added per reaction 1 h before
the end of rotation. Each sample was then washed four times
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with 600l of Triton buffer. Agarose and Sepharose beadswere
resuspended in 25 l of Laemmli buffer containing 5% -mer-
captoethanol and boiled for 5 min, and proteins were finally
separated by SDS-PAGE.
Surface Plasmon Resonance (SPR)—Experiments were per-
formed at 25 °C on a Biacore T-100 instrument (GE Health-
care). GST-UBZs or isolated UBZs were immobilized using an
amine-coupling method to a CM5 chip at an immobilization
density of 50–250 response units. Mono-Ub, Lys-48-, and Lys-
63-type di-Ub chainswere independently injected over the chip
at concentrations of 128, 64, 32, 16, 8, 4, 2, and 1 M, at 25
lmin1, with a 60-s association phase followed by a 5-min
dissociation phase. A buffer consisting of 10 mM HEPES, pH
7.5, 150 mM NaCl, 2 M ZnCl2, 5 mM -mercaptoethanol, and
0.05% Tween 20 was used throughout. Standard double refer-
encing data subtraction methods were used before analysis of
kinetics. Data analyses were performed using GraphPad Prism.
Size-exclusion Chromatography—Three confluent 10-cm
dishes of HeLa_Wrnip1-EGFP cells were extracted as for laser
scanning microscopy (see below) and lysed in 150 l of a buffer
containing HEPES 20 mM, pH 7.5, NaCl 50 mM, ZnCl2 2.5 M,
MgCl2 2 mM, dithiothreitol 1 mM, glycerin 10%, and Benzonase
nuclease 4 l/ml, supplemented with protease inhibitors. 4 mg
of proteins were loaded onto a Superose 6 10/300 GL column
(GE Healthcare) equilibrated with the same buffer used for cell
lysis. Gel filtration was performed at 0.3 ml/min, and 100 frac-
tions 0.2 ml each were collected.
Multiangle Laser Light Scattering (MALLS)—Static light
scatterings experiments with MALLS were performed at 25 °C
on a Mini-Dawn light scattering detector (Wyatt Technology)
set online with a Superdex S75 10/30 column (GE Healthcare),
in the same buffer used for SPR. Refractive index and light scat-
tering detectors were calibrated against toluene and bovine
serum albumin.
Induction of DNA Damage—For UVC treatment, cells on
coverslips were washed once in PBS and UV-irradiated at 254
nmwith a dose of 15 J/m2. Afterward, freshmediumwas added,
and cells were incubated for 24 h before being processed for
microscopy.
For hydroxyurea (Sigma) treatment, a stock solution of 100
mM in DMEM was added onto cells to a final concentration of
10mM.Cells were then incubated for 24 h before extraction and
processing for microscopy.
For topotecan (Hycamptin, GlaxoSmithKline) treatment,
cells grown on coverslips were placed in DMEM containing 1
M topotecan for 3 h. Afterward, cells were washed with PBS
and incubated in fresh medium for an additional 4 h before
being processed for microscopy.
Laser Scanning Microscopy—Cells were grown on coverslips
and transfected when indicated. For extraction with Triton
X-100, cells were washed once in PBS and once in CSK buffer
(10 mM PIPES, pH 6.8, 100 mM NaCl, 300 mM sucrose, 3 mM
MgCl2) and incubated for 3min inCSKplus 0.3%TritonX-100.
Cells were then washed three times with CSK, followed by one
wash in PBS and fixed in 2% paraformaldehyde. Subsequently,
cells were permeabilized for 10 min at room temperature, with
a 0.2% Triton X-100 solution in PBS. All cells were blocked
overnight at 4 °C in PBS containing 5% bovine serum albumin
and 0.1% Tween 20. Primary and secondary antibodies were
diluted in the blocking solution, and washes were performed in
PBS plus 0.1%Tween 20. The coverslipsweremounted on 10l
of aqueous mounting medium (Biomeda) placed on a glass
holder. Images were acquired by the LSM 510 META laser
scanning microscope (Zeiss).
Quantifications of Microscopy Images and Statistical
Analysis—To quantify the extent of co-localization between
Wrnip1-EGFP and RPA, 44 Z-stacks composed on average of 6
slices were processed using the freely downloadable Mac-
Biophotonics ImageJ software and the plugins “Colocalization
Highlighter” and “Object Counter3D.” To quantify the number
of eitherWrnip1- or Rad18-positive foci and their overlapping,
100 focal planes were analyzed using the LSM 510 META soft-
ware on the expert mode. Details of the methods used to define
intensity thresholds and foci are available upon request. To
measure the amount of protein resistant to extraction byTriton
X-100, 200 focal planes were examined for each experimental
condition. Each nucleus was selected, and themean intensity of
pixels per nucleus together with the standard deviation (S.D.)
were read. Comparisons were done using a Student’s t likeli-
hood test, considering the two distributions normal and their
variances dissimilar.
Yeast Two-hybrid System—The yeast strain Y190 was trans-
formed as described previously (16) with empty pYTH9 or
pYTH9-Wrnip1 as a bait, and pACT2-Wrnip1, pACT2-
Wrnip1 D37A, or Wrnip1 fragments in pACT2 prey. Yeasts
were grown on a synthetic dropout (SD) medium without
leucine and tryptophan (SD/Trp/Leu). Colonies appearing
after 3 days on the selectionmediumwere grown overnight in 5
ml of liquid selectionmedium. 0.5 ml of overnight culture were
grown in 4.5 ml of SD/Trp/Leu medium for 1–2 h, and the
concentration of cells was estimated bymeasuring theA600, and
the amount of cells per ml was adjusted by diluting with fresh
medium. 5l of cell suspension containing the same amount of
cells were spotted on SD/Trp/Leu agar plates as well as on
3AT agar plates. The 2nd day after spotting, cells were trans-
ferred to a Whatman filter paper and assayed for -galactosid-
ase activity with 5-bromo-4-chloro-3-indolyl--D-galactopyr-
anoside (X-gal; Roth).
RESULTS
Wrnip1 Can Interact with Both Mono- and Poly-ubiquitin—
We have recently described two Ub-binding domains, UBM
and UBZ, in the Y-family of translesion DNA polymerases.
UBM and UBZ recognize ubiquitylated PCNA and are impor-
tant for translesion synthesis (13). Following that discovery, we
have pursued a computational prediction of proteins bearing
either UBM or UBZ domains and grouped the latter into eight
groups (13). Among all proteins predicted to contain one or
more UBZ domains, those having a known or putative function
in DNA damage responses carried either a type 3 or type 4 UBZ
module (Fig. 1A). Compared with the UBZ of polymerase ,
which belongs to the UBZ3 class, a major difference in the
UBZ4 group was the fourth zinc ligand residue, which is a
Cys instead of His as in UBZ3. Other more subtle differences
between these two UBZ classes were also found. For
instance, the invariant Asp residue within the second zinc-
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binding dyad of UBZ3-type domains could also be found in
many UBZ4 fingers but was not as well conserved within the
UBZ4 family. The same trend held true for several other
residues (indicated by asterisks in
Fig. 1A), which have been recently
proposed to be involved in binding
to Ub (17). In contrast, the region
around the first zinc-binding dyad
appeared to be better conserved in
UBZ4 as compared with UBZ3
(Fig. 1A).
We focused our attention on
Wrnip1/Mgs1, which was recently
shown to selectively bind poly-Ub
chains and regulate the turnover of
ubiquitylated proteins (12). Wrnip1
has been genetically linked to the
ubiquitin ligase Rad18 in yeast and
chicken cells and proposed to func-
tion in response to stalling of DNA
replication forks (8, 18, 19). Because
Rad18 is known to accumulate in a
UBZ-dependent manner at sites of
DNA damage (20), and because
Wrnip1 UBZ is very similar to the
one in Rad18 (Fig. 1A), wewondered
whether the zinc finger domain of
Wrnip1 may regulate its subnuclear
distribution. We reasoned that by
studying this phenomenon we may
cast light on what appears to be a
general UBD requirement for pro-
teins containing them to form foci
(13, 21–24).
First, we wanted to confirm that
Wrnip1 can bind to Ub and that its
UBZ is necessary and sufficient for
such interaction. It has been
recently shown that Wrnip1 can
bind to poly- but not mono-ubiq-
uitin (12). To validate these findings,
we fused the amino acids 9–48
spanning theUBZdomain of human
Wrnip1 in-frame with GST,
expressed such fusion in E. coli, and
used it to pull down a mixture of Ub
chains varying in length from 2 to 7
monomers, linked either via lysine
48 or 63. Indeed, the UBZ domain of
Wrnip1 could bind to both types of
chains (data not shown). However,
when overexpressed in HEK 293T
cells, Wrnip1 could also interact
with mono-ubiquitin either fused
in-frame with GST and bound to
glutathione-Sepharose or coupled
to agarose beads (Fig. 1B). In con-
trast, Wrnip1 did not bind to the
GST-fused Ub mutant I44A (Fig. 1B). This residue lies in the
so-called “hydrophobic” patch on the surface of ubiquitin, and
it is crucial for the interaction of Ubwith themajority of known
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UBDs (25, 26). In agreement with previous findings (12), we
also found that mutation to alanine of the highly conserved
aspartate residue at position 37 in the human and mouse
sequences of Wrnip1 (D37A) abolishes binding to both mono-
and poly-Ub. This mutant corresponds to the previously
described D652Amutant of polymerase  (13), which does not
disrupt the overall structure of the zinc finger, being placed in
the outer surface of the adjacent -helix involved in direct
interaction with Ub (17). When overexpressed in HEK 293T
cells, the Wrnip1 D37A mutant could not be pulled down by
GST-Ub, unlikewild-typeWrnip1 (Fig. 1B). Similarly, when the
corresponding aspartate residue at position 221 in Rad18 was
mutated to alanine, its interactionwithmono-Ubwas abolished
(Fig. 1B).
To gain further insight in the binding properties of Wrnip1
UBZ, we fused it in-frame with GST and used the purified
fusion protein for SPR with a Biacore flow system. As shown in
Fig. 1C, clear binding curves could be seen for the wild-type
protein, with a dissociation constant for the complex between
wild-typeGST-UBZWrnip1 bound to the chip and freemono-Ub
estimated to be 46 M from the equilibrium responses. The
binding displayed fast-on fast-off kinetics, as expected for a low
affinity interaction. In the case of the D37A mutant, no signifi-
cant binding was seen with Ub concentrations up to 128 M,
confirming a dissociation constant for ubiquitin far in excess of
this value. To exclude that the GST moiety affects the interac-
tion between UBZ and Ub, we cleaved it by thrombin and cou-
pled the purified UBZ domain to the chip for SPR (Fig. 1D).
Similarly, we obtained a KD of 40 M in the case of wild-type
Wrnip1 UBZ bound to mono-Ub (Fig. 1D). As a control, we
used the purified UBZ of Rad18 and obtained a KD of 38 M,
consistent with the previously published value of 42 M for
GST-UBZRad18 (14). These data demonstrate that Wrnip1 and
Rad18UBZs can bindmono-Ubwith comparable affinities, not
surprising given their high sequence similarity. However, we
observed a differencewhen di-Ub chains linked either via lysine
48 or 63 were flown over the UBZs ofWrnip1 and Rad18. In the
case ofWrnip1,KD values for both Lys-48- andLys-63-typeUb2
chains were slightly reduced, indicating a stronger interaction,
whereas in the case of Rad18 this was observed only for Lys-63
chains. In contrast, the KD value of Rad18 for Lys-48-linked
di-ubiquitin was around 100 M (Fig. 1D). These results dem-
onstrate that Wrnip1 and Rad18 UBZs can bind both mono-
and distinct poly-Ub chains and highlight a difference in chain-
type selectivity between the two domains, despite their
sequence similarity.
Wrnip1 Is Concentrated in Replication Factories and Other
Subnuclear Structures—To gain knowledge on the biological
function of human Wrnip1, we decided to examine its nuclear
distribution by laser scanning microscopy. Among several
tested antibodies, only one managed to detect Wrnip1 in fixed
cells. Typically, Wrnip1 was confined in the nucleus, where it
was mostly diffuse and excluded from nucleoli (data not
shown). To visualize potential Wrnip1-positive subnuclear
structures, we pretreated the samples with a mild detergent
solution. This procedure has been largely applied to a variety of
other nuclear proteins, unmasking distribution patterns other-
wise shaded by their nucleoplasmic fraction (see for example
Refs. 27, 28). Indeed, after extraction with Triton X-100, most
of the diffuse Wrnip1 signal disappeared, and the remaining
portion was predominantly detectable as discrete foci visible in
all cells (Fig. 2A). Such focal structures were typically spread all
over the nuclear sections examined, rarely found in nucleoli,
and appeared round and isolated. Interestingly, in female HeLa
cells, but not inMRC5male fibroblasts,Wrnip1was also spread
in large patches (Fig. 2A), reminiscent of chromosomal territo-
ries (29). The antibody used seems rather specific in native con-
ditions, as it detected only one prominent endogenousWrnip1
band in immune precipitation (supplemental Fig. 1A).
To enhance the detection sensitivity and better visualize
Wrnip1 structures, we established HeLa cells stably expressing
low amounts of EGFP-tagged human Wrnip1 (HeLa_Wrnip1-
EGFP). As expected,Wrnip1-EGFPwas exclusively localized in
the nucleus (Fig. 2A), and its average expression was compara-
ble with that of endogenousWrnip1 in the same cells and in the
parental HeLa cell line (supplemental Fig 1B). The localization
of Wrnip1-EGFP fully mirrored that of endogenous Wrnip1,
with focal structures and patches that completely overlapped
with endogenous Wrnip1 (Fig. 2A). Moreover, Wrnip1-EGFP
and endogenous Wrnip1 co-fractionated in high molecular
weight complexes (supplemental Fig. 1C), further indicating
that the recombinant protein can recapitulate the behavior of
endogenous Wrnip1. In the same fractionation experiment,
Wrnip1 and Wrnip1-EGFP were also found to co-fractionate
with PCNA and polymerase , both of which have been previ-
ously shown to be in complex with Wrnip1 (9, 30).
Because Wrnip1 has been linked to replication, possibly
operating in the bypass of stalled replication forks (3, 8, 9, 11,
18), we became interested in verifying whether any of the focal
structures visualized in human cells contain replication facto-
ries. For this purpose, we stained HeLa_Wrnip1-EGFP cells
with antibodies recognizing specific replication factors. In cells
FIGURE 1. Wrnip1 is a mono- and poly-Ub-binding protein. A, Wrnip1 contains a UBZ4 domain. Multiple alignment of UBZ3 (upper part) and UBZ4 (lower part)
zinc finger domains is shown. Invariant or conserved in at least 40% of the sequences residues are shown on a black or gray background, respectively. The two
uppermost lines indicate the secondary structure (E  extended, H  helix) of polymerase  and the residues (asterisks) with NMR signals that were perturbed
upon Ub binding (17). The beginning and the end of each domain are indicated by the number of their first and last amino acids, respectively. Accession
numbers are shown for each protein and refer to the NCBI Protein data base. Known or proposed functions of each protein are indicated on the right. B, Wrnip1
UBZ is necessary for interaction with mono-Ub. Left panel, GST-Ub and Ub-agarose pulldown of mouse FLAG-Wrnip1 overexpressed in HEK 293T cells. 2nd panel
from the left, GST-Ub I44A pulldown of M. musculus (Mm) FLAG-Wrnip1 overexpressed in HEK 293T. 2nd panel from the right, GST-Ub pulldown of M. musculus
FLAG-Wrnip1 D37A overexpressed in HEK 293T. Right panel, pulldown of Myc-tagged human Rad18 wild-type and D221A with GST-Ub. IB, immunoblot.
C, Wrnip1 UBZ is a mono-Ub-interacting domain. Left graphs, sensorgrams obtained for different concentrations of free mono-Ub flown over wild-type (upper
left graph) and D37A (lower left graph) GST-UBZWrnip1. KD values were calculated by fitting a Langmuir binding isotherm to the data (right graph). D, Wrnip1 and
Rad18 UBZs have a different selectivity for di-ubiquitin chains. Isolated UBZs of Wrnip1 (left graph) and Rad18 (right graph) were coupled to a chip for SPR, and
responses to increasing concentrations of either mono-Ub, Lys-48-, or Lys-63-linked di-ubiquitin chains were measured. The equilibrium responses obtained
were plotted against Ub concentration, and KD values were calculated from these Langmuir binding isotherms.
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recognizable as being in S phase by the presence of RPA foci,
44% of Wrnip1-EGFP-positive foci on average fully co-local-
ized with replication factories, and 17% of replication foci con-
tained Wrnip1 (Fig. 2B). In the same cells, we also observed
manyWrnip1 foci partially overlappingwith or abutting to rep-
lication foci (Fig. 2B, blue arrows). Similar results were obtained
after visualization of replication factories with an antibody
against PCNA (supplemental Fig. 2A).
The identity of Wrnip1 foci in non-S phase cells and of foci
not overlapping with replication factories still remained
obscure. To cast light on this intriguing issue, we undertook an
hypothesis-driven approach and first tested for Wrnip1 co-lo-
calizationwith two subnuclear domains reminiscent in size and
morphology ofWrnip1 foci: Cajal bodies andPMLbodies. Cajal
bodies are marked by coilin and have been functionally linked
to small nuclear RNA biogenesis, telomerase RNAmaturation,
and transcription (31). No overlap between Wrnip1 foci and
Cajal bodies was detected (data not shown). In contrast, in
asynchronous HeLa_Wrnip1-EGFP cells, threeWrnip1 foci on
average stained positive for PML per focal plane (Fig. 2C). A
similar trend was seen between endogenous Wrnip1 and PML
in the parental HeLa strain (supplemental Fig. 2B). Altogether,
these data reveal a composite nuclear topography for Wrnip1
and demonstrate that Wrnip1-EGFP can recapitulate the
behavior of endogenous Wrnip1 by localizing to physiological
structures such as replication factories and PML bodies.
Wrnip1 Foci Are Dynamic during the Cell Cycle and after
Replication Fork Stalling—Because in asynchronized cell cul-
tures Wrnip1 foci of heterogeneous size can be appraised in
various numbers in all nuclei (data not shown), we asked
whether Wrnip1 is expressed in all the phases of the cell cycle.
For this purpose, we synchronized HeLa cells with a double
thymidine block and monitored the expression of endogenous
Wrnip1 byWestern blot. Comparable amounts ofWrnip1 pro-
tein could be detected in all the phases (Fig. 3A). We next won-
dered if the distribution ofWrnip1 foci changes throughout the
cell cycle. Using the same procedure, we synchronized
HeLa_Wrnip1-EGFP cells and fixed them at various time
points after releasing the thymidine block. Wrnip1 foci were
clearly present in all the four phases of the cell cycle, within
most of the nuclei examined. During S phase,Wrnip1 foci were
quite abundant, round, and relatively small (Fig. 3A, 0 h after
thymidine withdrawal). This is consistent with the co-localiza-
tion pattern between Wrnip1 and replication factors as
FIGURE 2. Wrnip1 is concentrated in various subnuclear structures. A, Wrnip1 is localized in punctated and patch-like structures in the absence of induced
DNA damage. Endogenous Wrnip1 in HeLa and MRC5 cells (left panels). Endogenous and recombinant Wrnip1 fully co-localize in HeLa cells stably expressing
low levels of Wrnip1-EGFP (right panels). Wrnip1-EGFP was detected using the fluorescence signal from EGFP, whereas endogenous Wrnip1 was probed with
a commercially available anti-Wrnip1 antibody. B, some Wrnip1 foci correspond to replication factories. HeLa_Wrnip1-EGFP cells were stained with an antibody
against RPA. Wrnip1-EGFP was detected using the fluorescence signal from EGFP. Rectangles on the top and right side of each squared image represent signal
profiles along the z axis. Histograms on the right, quantification of the percentage of Wrnip1-EGFP foci overlapping with RPA and of RPA foci co-localizing with
Wrnip1. C, some Wrnip1 foci overlap with PML bodies. HeLa_Wrnip1-EGFP cells were stained with an antibody against PML. In all the images, white arrows
indicate examples of co-localizing proteins and blue arrows abutting foci.
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described before (Fig. 2B). When cells reached late S/early G2
phase, the pattern changed, andWrnip1 foci often appeared in
linear or circular groups (Fig. 3A, 5 h after thymidine with-
drawal). Many round-shaped Wrnip1 foci were again visible
during mitosis and in early G1 (Fig. 3A, 9 h after thymidine
withdrawal and small panels boxed in red). Interestingly, a
Wrnip1 signal could be also detected at the cleavage furrow
(Fig. 3A, white arrows in the red boxed panels), which has been
recently shown to be enriched in ubiquitylated proteins (32).
Finally, whenmost of the cells were synchronized at the bound-
ary between G1 and S phase, the number of Wrnip1 foci
dropped, and they appeared larger (Fig. 3A, 12 h after thymi-
dine withdrawal). These data indicate that, besides being
detected in large numbers during S phase, when many of them
overlap with replication factories, Wrnip1 foci are also present
in all the other phases of the cell cycle. This observation sup-
ports the idea that Wrnip1 could play extra-replicative
functions.
We then wondered if and how agents known to stall replica-
tion forks affect the number and/or morphology of Wrnip1
foci. For this purpose, we treated HeLa_Wrnip1-EGFP cells
with UVC light, hydroxyurea, or the topoisomerase I inhibitor
topotecan and monitored their influence on Wrnip1 localiza-
tion. In all cases, but particularly after UVC, the amount of
Wrnip1-positive foci increased, and they tended to become
confluent (Fig. 3B). When we quantified the mean number of
foci per focal plane, a significant difference emerged between
unstimulated and UVC-irradiated cells (Fig. 3B). We also
observed that, upon UVC, the amount of Triton X-100-resist-
ant Wrnip1 became significantly higher (p  0.001) as com-
pared with untreated cells, whereas the overall Wrnip1 protein
levels remained constant (Fig. 3B). Altogether, these data dem-
onstrate thatWrnip1 foci respond to conditions that block pro-
gression of replication forks by undergoing a dramatic re-orga-
nization in number, morphology, and solubility.
Type 4 UBZ of Wrnip1 Is Essential for Foci Formation—We
have previously reported that the UBM and UBZ domains of Y
polymerases are required for their presence inside nuclear foci
representing replication factories (13, 21). Similarly, the integ-
rity of Rad18 zinc finger is essential for its accumulation at sites
of DNA damage (20). Because we also detected Wrnip1 foci
both in nontreated cells (Fig. 2A) and upon replication forks
stalling (Fig. 3B), we sought to verify whether this distribution
requires its UBZ domain.
For this purpose, we examined by laser scanning microscopy
HeLa cells stably expressing either wild-type EGFP-tagged
Wrnip1 or its Ub-binding-deficient D37A mutant. After pre-
treating the coverslips with Triton X-100, no foci could be
detected in cells expressing theD37Amutant, independently of
UVC treatment (Fig. 4A, left panels). The same result was
obtained after overexpression in HeLa cells of an EGFP-tagged
Wrnip1 lacking the UBZ domain (Fig. 4A, left panels). In agree-
ment with previous reports (20, 33), Rad18 similarly required
its Ub-binding ability to be seen inside foci inUVC-treated cells
(Fig. 4A, right panels). Additionally, we are the first to report
that the same behavior applies to Rad18 in untreated cells (Fig.
4A, right panels).
Because Wrnip1 and Rad18 share a very similar UBZ4
domain (Fig. 1A), we wondered whether this would be suffi-
cient to target these two proteins to the same set of foci. In
HeLa_Wrnip1-EGFP cells transfected with Myc-Rad18, a rela-
tively small fraction of Wrnip1- and Rad18-positive foci over-
lapped (Fig. 4B, left panels and graph). After treating cells with
UVC light, the extent of co-localization significantly increased
(p  0.001), but it never reached a complete overlap in all cells
(Fig. 4B, right panels and graph). These data demonstrate that
Wrnip1 and Rad18 co-segregate in a subset of nuclear foci,
possibly based on binding of their UBZs to the same ubiquity-
lated targets. However, they also reveal that very similar UBZ
domains are not sufficient to drive full co-localization of UBZ-
containing proteins into the same foci.
To further clarify these issues, we constructed Wrnip1 chi-
meras in which the UBZ domain was substituted by either the
N-terminal UBM domain of polymerase , the type 3 UBZ
domain of polymerase , or the type 4 UBZ of Rad18. In addi-
tion, we made a Myc-tagged Rad18 chimera by exchanging the
UBZ domain with the one of Wrnip1. We assume that such
chimeras were properly folded because they all retained several
properties ofWrnip1, such as nuclear localization and the abil-
ity to bind ubiquitin (supplemental Fig. 3A). Nevertheless, only
Wrnip1 UBZRad18 and Myc-Rad18 UBZWrnip1 chimeras were
detectable inside nuclear foci like the wild-type counterparts
(Fig. 4C). In contrast, all the other chimeras showed a spread
distribution (Fig. 4C) similar to that ofWrnip1 D37A (Fig. 4A).
Our data indicate that the presence ofWrnip1 andRad18 inside
focal structures specifically depends on their type 4 UBZ
domains, rather than on mere Ub binding ability. We hypoth-
esize that the specific amino acid sequence and/or conforma-
tion ofWrnip1 and Rad18 Ubiquitin-binding domains are nec-
essary for them to contact an unknown “attractor” inside
nuclear foci.
Wrnip1 Oligomerization via Its C Terminus Contributes to
Foci Localization—It has been shown previously that Wrnip1
forms homo-oligomers (11) and that its Ub-binding zinc finger
may be involved in this process (34). Similarly, it has been dem-
onstrated that Rad18 can dimerize (35) and that its UBZ
domain is indispensable for this phenomenon (36). However, in
contrast with these findings, the UBZ domain in Rad18 has
been recently disproved to form oligomers in vitro (14). There-
fore, it remains unclear whether type 4 Ub-binding zinc fingers
can mediate oligomerization, which in turn could be required
for proper localization. To clarify this issue, we first checked
whetherWrnip1D37A,which does not bind toUb (Fig. 1,B and
C), could still interact with wild-typeWrnip1 in vivo. In a yeast
two-hybrid assay, Wrnip1 interacted with both Wrnip1 wild-
type as well as with the D37A mutant (Fig. 5A). Equally, an
interaction was detected between Wrnip1 wild type and a
fragment encompassing the residues 397–665 of Wrnip1,
but not with fragments containing either the residues 1–250
(including the UBZ domain) or 200–400 that contain the
ATPase domain (Fig. 5A). In agreement with these findings,
the previously described Wrnip1 UBMPol chimera was still
able to co-immunoprecipitate with wild-type Wrnip1 (Fig.
5B), further indicating thatWrnip1 UBZ is not important for
homo-oligomerization.
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To conclusively exclude a role of Wrnip1 UBZ in oligomer-
ization, we checked whether purified UBZWrnip1 expressed in
E. coli is present in solution as either a monomer or an oli-
gomer. Using MALLS, we measured a mass of 5.8 kDa for the
amino acid sequence 9–48 of human Wrnip1, which encom-
passes theUBZ domain (Fig. 5C). This value is consistent with a
monomeric UBZ domain, which has a molecular mass of 4.9
kDa. Furthermore, the mass estimated from the scattered light
did not vary across the UBZ peak while being eluted from the
size-exclusion chromatographic column, proving that the sam-
ple was monodisperse even at high concentrations (Fig. 5C).
Altogether, our data indicate that theUBZdomain ofWrnip1 is
not involved in oligomerization. On the contrary, the C-termi-
nal portion of Wrnip1 seems relevant for this process.
Finally, we asked whetherWrnip1 oligomerization is impor-
tant for its presence inside nuclear foci. For this purpose, we
constructed various FLAG-tagged Wrnip1 fragments lacking
progressively longer amino acid stretches from the C terminus.
In HEK 2393T cells, all the fragments were expressed at higher
levels than wild-type FLAG-Wrnip1 and bound to mono-Ub
(supplemental Fig. 3B and data not shown). Only the fragment
containing amino acids from 1 to 450 (encompassing the UBZ
and theAAA domain, but lacking the predicted leucine zipper
at position 496–547 (34)) retained appreciable ability to bind
Wrnip1, although deficient in comparison with the wild-type
protein (supplemental Fig. 3B). In contrast, the fragment 1–380
was almost unable to bind GST-Wrnip1. In HeLa_Wrnip1-
EGFP cells, the fragment 1–450 was not distributed inside foci
but completely diffuse inside the nucleus (Fig. 5D). The same
patternwas observed in the case of all other fragments (data not
shown). In contrast, full-length FLAG-Wrnip1 was enriched
within focal structures that also contained Wrnip1-EGFP (Fig.
5D). In conclusion, these data confirm our finding that the
C-terminal third ofWrnip1 is required for oligomerization (Fig.
5A). Additionally, they reveal that already the last 215 amino
acids ofWrnip1, which appear to contribute to oligomerization
(supplemental Fig. 3B), are critical for Wrnip1 presence in
nuclear foci.
DISCUSSION
In all organisms, recovery of stalled DNA replication forks is
critical to maintain genomic stability and can occur through
multiple mechanisms and factors (1). In S. cerevisiae, Mgs1
(maintenance of genomic stability 1) is required to ensure
genomic stability (3) and is likely to operate in a DNA damage-
tolerance pathway alternative to Rad6-Rad18 (8, 9). In mam-
mals, the orthologue ofMgs1,Wrnip1,was cloned as a binder of
the helicase (Wrn) that is missing in the premature aging
Werner syndrome (37) and functions in various DNA transac-
tions, including replication (4). Human Wrnip1 has been
shown to interact withDNApolymerase  and inferred to oper-
ate in the re-start of stalled replication forks (11). However, the
exact function(s) and regulation of Wrnip1 in human cells
remain to be elucidated.
In this study,we provide a comprehensive structure-function
analysis of Wrnip1 in human cells and show that Wrnip1 is
distributed in a composite set of subnuclear structures. Unrav-
eling the identity of these structures may cast light on the myr-
iad of potential Wrnip1 functions in the cell. Besides a diffuse
fraction, a part ofWrnip1 in the nucleus ismainly concentrated
in a mix of punctated focal structures (Fig. 2A). Despite having
been cloned as a Werner syndrome helicase (Wrn) binder, the
distribution ofWrnip1 in undamaged cells does not mirror the
one ofWrn. In line with several other reports (38–40), by light
microscopy we were able to detect Wrn inside nucleoli but not
in punctated structures.5 Wrnip1 foci can be clearly seen
throughout the cell cycle, but prominently during the S phase
(Fig. 3A). At this time, many Wrnip1 foci overlap with replica-
tion factoriesmarked either by the RPA and PCNA (Fig. 2B and
supplemental Fig. 2A) or by Rad18 (Fig. 4B). This observation
strengthens the evidence accumulated so far thatWrnip1 func-
tions at DNA replication forks and can interact with certain
replication factors, such as PCNA, polymerase , and FEN1
(9–11). Additionally, a dramatic re-organization of Wrnip1
topography is seen in the nucleus after treatment with UVC,
topotecan, or hydroxyurea; the amount of detergent-resistant
and plausibly chromatin-boundWrnip1 significantly increases,
as does the number of foci (Fig. 3B). Also, the percentage of
Wrnip1 foci co-localizing with replication forks significantly
increases (Fig. 4B), suggesting that human Wrnip1 may deal
with stalled replication forks, as inferred previously from yeast
studies (3, 8, 9).
The distribution of Wrnip1 in the nucleus, however, is not a
mere reflection of the one of replication sites. Wrnip1 foci are
visible in all the phases of the cell cycle, possibly representing
various functional pools of this protein. In an effort to unravel
the identity of these structures, we found thatWrnip1 is always
present in a subset of PML bodies (Fig. 2C), independently of
the cell cycle phase. PML bodies have been linked to a plethora
of functions, including regulation of transcription, stress
responses, alternative lengthening of telomeres, and establish-
ment of heterochromatin after replication (41). Whether PML
bodies represent a storage or an active site for Wrnip1 and
whether, like PML,Wrnip1 is involved in heterochromatin for-
mation are exciting topics for future investigations.
5 N. Crosetto, M. Bienko, and I. Dikic, unpublished observations.
FIGURE 3. Wrnip1 foci are dynamic. A, Wrnip1 foci are visible throughout the cell cycle. HeLa_Wrnip1-EGFP cells were synchronized by a double thymidine
block. Top, the overall amount of endogenous Wrnip1 remains constant throughout the cell cycle. WCE, whole cell extract. Left column panels, cell cycle phase
distributions assessed by propidium iodide stain and cytofluorimetry. Right column panels, low magnification fields of asynchronized or synchronized HeLa
cells. The small panels show representative magnifications of one or two cells found in the bigger adjacent panels. The five small panels boxed in red display
nuclei in subsequent phases of mitosis. White arrows mark Wrnip1 signal at the cleavage furrow. Wrnip1-EGFP was detected using EGFP fluorescence. IB,
immunoblot. DAPI, 4,6-diamidino-2-phenylindole. B, Wrnip1 is re-distributed following DNA damage. Top, HeLa_Wrnip1-EGFP cells were treated with the
indicated DNA-damaging agents, extracted, fixed, and used for microscopy. In the middle, quantification of the images above. Each green histogram represents
mean values, whereas black bars mark standard deviations. P, result of a Student’s t test comparing the indicated distributions. Bottom, the overall amount of
Wrnip1 does not change upon UVC treatment. WCE, whole cell extract; IB, immunoblot; HU, hydroxyurea.
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Such a composite topography is not limited to Wrnip1,
because a similar pattern is observed in the case of certain DNA
damage-responsive factors outside the S phase and in the
absence of induced DNA damage. For example, the DNA dam-
age tolerance ubiquitin ligase Rad18 is present in punctated
structures in all the nuclei of asynchronized cells (20).5 Approx-
imately 15% of these foci also containWrnip1 (Fig. 4B).Wrnip1
foci in non-S phase cellsmight represent inactive depots or sites
of extra-replicative functions, such as DNA damage repair or
chromatin remodeling. Supporting the latter hypothesis, it is
worth mentioning that Wrnip1 is an AAA ATPase (3), with
similarities to the protein chaperone and extractor Cdc48/p97.
LikeWrnip1, Cdc48/p97 is a Ub-binding protein and anAAA
ATPase able to extract protein complexes involved in a multi-
FIGURE 4. Wrnip1 UBZ is essential for its localization to nuclear foci. A, Wrnip1 and Rad18 UBZ are indispensable for their presence in nuclear foci,
independently of DNA damage. Left panels, HeLa_Wrnip1-EGFP either wild-type or D37A as well as HeLa cells transfected with Wrnip1 	UBZ-EGFP were
extracted, fixed, and used for microscopy. Right panels, HeLa_Wrnip1-EGFP cells transfected with either wild-type or D221A human Myc-tagged Rad18 were
similarly processed. Wrnip1-EGFP was detected using EGFP fluorescence, Myc-Rad18 using an anti-Myc antibody. B, Wrnip1 and Rad18 co-localization is
significantly enhanced by UVC irradiation. HeLa_Wrnip1-EGFP cells were transfected with Myc-tagged Rad18 and either treated with UVC irradiation (right) or
not (left). The white square encloses the area that is magnified in the small panels. Wrnip1-EGFP was detected using the fluorescence from EGFP, whereas
Myc-Rad18 using anti-Myc antibodies. Histograms on the right, quantification of Wrnip1-positive foci containing also Rad18 and of Rad18-positive foci
containing Wrnip1, with or without prior UVC irradiation. The distributions were compared by a Student’s t test, and the calculated p values are displayed.
C, type 4 UBZ is required for Wrnip1 and Rad18 to be localized in foci. Left, HeLa cells transfected with Wrnip1-EGFP wild-type and various UBZ chimeras. Right,
HeLa cells transfected with Myc-Rad18 wild-type and UBZWrnip1 chimera. Wrnip1-EGFP was detected using EGFP fluorescence, Myc-Rad18 using an anti-Myc
antibody.
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tude of unrelated functions (42, 43). Therefore, we can envision
a scenario in which Wrnip1 acts as an ATPase chaperone
within a broad set of subnuclear sites involved in different DNA
transactions and not only replication.
Independently of their identity, the presence ofWrnip1 in all
the described heterogeneous structures seems to be highly reg-
ulated and specifically depends on its UBZ. TheUBZ domain of
Wrnip1 is very similar to the one in theDNAdamage-tolerance
FIGURE 5. Wrnip1 oligomerization is UBZ-independent and contributes to its presence in foci. A, Ub-binding ability of Wrnip1 is not required for oligomerization.
Yeast two-hybrid assay with the Y190 strain. Empty, control yeast transformed with the indicated empty vectors. D37A, yeast transformed with Wrnip1 D37A. 1–250,
200 – 400, 397– 665, yeast transformed with fragments of Wrnip1 encompassing amino acids from 1 to 250; from 200 to 400, and from 397 to 665, respectively.
B, Wrnip1 UBMPol chimera oligomerizes with wild-type Wrnip1. HEK 293T cells were transfected with FLAG-Wrnip1 together with either Wrnip1-EGFP or Wrnip1
UBMPol-EGFP chimera. Protein complexes were immune precipitated with an anti-FLAG antibody and visualized by SDS-PAGE and Western blot. *, mono-ubiquity-
lated Wrnip1. IB, immunoblot. C, Wrnip1 UBZ is a monomer in solution. MALLS using purified UBZWrnip1 cleaved from GST by thrombin. The left peak represents Wrnip1
UBZ, and the right peak is from small molecules. Calculated and measured molecular weights of UBZWrnip1 are shown. D, C terminus of Wrnip1 is required for its
presence in foci. HeLa_Wrnip1-EGFP cells were transfected with FLAG-tagged Wrnip1 wild type or lacking the last 215 amino acids.
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factor Rad18, and the UBZ of bothWrnip1 and Rad18 can bind
to mono-Ub with comparable affinities (KD 40 M). Wrnip1
and Rad18 also bind to Lys-63-type chains stronger than to
mono-Ub. However, Rad18 appears to be able to discriminate
between Lys-63 (KD 20M) and Lys-48 chains (KD 100M).
This selectivitymight contribute to the different distribution of
Wrnip1 and Rad18 foci in vivo (Fig. 4B). Although at present
the structural basis of this selectivity is unknown, we can trace
parallels with the behavior of another type of UBD, the ubiq-
uitin-associated domain (UBA). In a recent survey on more
than 30 UBAs, it was shown that one group preferentially binds
Lys-48-linked chains, a second group Lys-63 chains, whereas a
third one can bind both types (44). Moreover, in different stud-
ies it was shown that the UBA domains of hHR23a and Mud1
bind between the twoUbmoieties of a Lys-48-type di-Ub chain
in a “sandwich-like” manner (45, 46), whereas the UBA domain
of hHR23a binds to Lys-63-linked di-Ub chains in a similar way
as it binds to mono-Ub (47, 48).
The mechanistic link between foci formation and Ub-bind-
ing ability appears to be less clear. Indeed, as previously shown
for Y-family polymerases (13, 21) and more recently for Rap80
(24, 49), also in the case of Wrnip1, a Ub-binding module is
necessary to be localized in nuclear foci, independently of DNA
damage. However, Ub-binding ability per se does not suffice for
Wrnip1 to be present in different subnuclear structures. A
Wrnip1 UBZPol chimera is not localized inside foci, despite
carrying a zinc finger domain similar to the one ofWrnip1 (Fig.
4C). Moreover, Wrnip1 and Rad18, which carry very similar
UBZ4-type domains, do not fully co-localize, even after UVC-
induced DNA damage (Fig. 4B). Therefore, UBZ alone is likely
insufficient to drive Wrnip1 to various subnuclear structures
and additional binding sites may determine specificity toward
certain loci. This phenomenon has been described previously
for translesion polymerases  and , which concentrate in UV-
induced foci via a dual interaction with ubiquitylated PCNA
that involves both their UBD and PIP box (PCNA-interacting
peptide) (13). To this respect, it is interesting that a C-terminal
deletion of Wrnip1, reducing its ability to oligomerize, is
already sufficient to prevent its localization inside nuclear foci
(Fig. 5D).
In conclusion, our study revealsWrnip1 as a newmember of
a growing family ofUBD-containing proteins that use their spe-
cific UBDs to localize in nuclear focal structures, not only after
induced DNA damage but also in unstimulated cells. Our mor-
phological data also indirectly highlight possible functions of
Wrnip1 in human cells. Beside replication, Wrnip1 ATPase
could be a chaperone engaged in several transactions in the
nucleus.
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